The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
The stream of rfq or extensions seemed to have been true, just not that many our way yet. Very frustrating. I can't imagine on head to head performance smarteye are unlikely to be better on performance and we have evidence that may be case re BMW. I guess they sell on price and OEM haven't bought into the optical path and mirror siting cost advantage yet or they prefer Gentex for mirror or prefere the devil they know in case of kia/hyundai. Would be nice to see some extensions for blue cruise and super cruise. Come on PMG a nice Christmas present or two would be nice I have been a good boy all year.....
As CES is early Jan might there be some staging of Magna announcements to coincide. If we are bidding for dms/OMS indirectly we won't be getting notification directly. Although market sensitive news is supposed to be disclosed when above a % of market cap ot could follow that as Magna is huge in comparison a mirror (or another site) win which includes us via magna might not get disclosed until grouped at a large event to.make more noise? QUALCOMM announcements came.ot at CES amd although we have a 'preconfigured' chip option in snapdragon ride etc we are necessarily gonna get the dms as that will be functionalised by tier ones via the optical path and LED sitings etc. Might we have to wait through desperate December to get to Jammy January?? My feel is that we won't be bidding independently over the last 18 months with most routed via a tier 1 and as PMG indicates we can't announce until tier 1 announces. Very frustrated here
Https://www.heyfordpark-ic.co.uk/2023/11/21/conserv-bioscience-grows-team-of-vaccine-specialists/
News from Conserv Bio the senior partner for the the flu vaccine and malaria saliva vaccine we have rights on via our stranded asset. Something may still happen here that could trigger a small special dividend.
I don't have level 2 access but 500k shares aggregate shares traded worth about 30k or so and we are down 2.5% c5millon quid of mcap.
News please 🙏
Any links to a very up-to-date cointracking portfolio that has our current holdings with TIA??
It's free to get access to redeye and could be useful for some Nordic companies we might not encounter too.much news on in UK without turning a lot of rocks of over. Any questions need some up votes - just saying...
Fancy asking some interesting questions of smarteye analyst / broker Redeye re Smarteye?
Link below -- use wisely ;-)
https://www.redeye.se/research/948036/smart-eye-investment-case-de-risked?conversation=qa&utm_source=follower&utm_medium=email
Knowing the market space that NCYT operate in with extreme detail David Allmond as a more Pharma orientated C suite experienced individual may have been a poor move on both sides. However NCYT at the time he joined was a slow moving car crash as Covid was beginning to be over with testing locked out to the big guys in hospital market like roche, abbott and thermo and thermo got a lot of the lighthouse work, the test suite they had was a one trick pony and the regulatory overheads were massively increased with CTDA and that was a nightmare. They bought and marketed the IT-IS systems which are quite unloved by users and marketed falsely as point of care where they are clearly unsuited for this. The DHSC dispute could go either way but having put together a consortium bid to run and supply a lighthouse lab I am so grateful we lost that bid as the site ultimately never opened and the cost exposure would have left us with.multi million liabilities. They.may win their case, they have cash but have no real strategy and maybe there is a decent business hiding in their but investor base was a lot of new covid lockdown funds chasing the price and its ultimate high was fantasy land stuff valuation. Non of the share price decline is really attributable to DA and the current price is roughly fair.imho the days of over a quid for them long gone without real investment in product and certification and a decent outcome vs dhsc. DA may have been honest about what they needed to do, the rest of board disagreed and that may have led to leaving. Will be interesting in how the dynamic of DA and JS will develop.
Beat me to it. Yep no KPIs. The fact that we disclose vs the non broken out auto and no idea of cars on road I really don't know what to make of that. They clearly are increasing cars on road but it makes me wonder their unit pricing is very low ir numbers on road disappointing? We moan about us not shouting from roof tops but surely as king of dms they would be ramming cars on road down investors throats?
Just check on the ir portal for smarteye i think in the smarteye q2 presentation they mentioned 1.3m so they will be in advance but as they don't reliably define cars on road I am guessing they may make a song and dance of 1.5m??
This softer quarter looks to be industry wide. Maybe some impact from strikes in US and as another poster mention model switchover period. May also explain house coverage from Redeye for Smarteye being revised downwars for the quarter. Will be interesting to see their progress tomorrow. Any views on if 1.3m vehicles is likely still behind cars on road for smarteye? Next few months/ quarter for RNS and next 4 quarters to show ramp up is confirmed.
Absolutely Future logic! However the last years grind down on small caps gas been relentless and the market has not been particularly forgiving and even if we blow doors off what the market thinks is unpredictable.....
Https://corporate.tobii.com/investors/financial-reports/2023/11/tobiis-interim-report-third-quarter-2023-weak-quarter-but-target-for-q4-profitability-remains
Tobii down 20odd percent after missing quarter guidance. Best hope we do our numbers and the figures are received well. MCAP of tobii looking interesting for consolidation purposes.
Looking at their total revenue in 2024 for auto is 23m usd equivalent. Their research arm in 2024 gonna do similar if projected becomes reality. Their automotive includes aftermarket and NRE as I understand it. What is concensus forecast for SEE in comparative quarter for cNov 2024. If aftermarket and monitoring scales to 6 figure installs and we deliver our booked revenue and execute as planned then some pointy questions for Martin Krantz on how firm the many many many oems and models they were awarded we actually cancelled or retendered?
Wonder if some kind of complex equity swap/financing to build out a wider offer? Maybe the.doldrums at cab payments being seen as a potential to build a business and take advantage of cabs woes. Bit of housekeeping on costs and scale business quicker/cheaper??
Bit more volume comparatively too. 50 grand is a decent chunk of change. Hopefully all buys and one buyer building a stake but the point made earlier in thread re getting hold of 5% will need a lot of buying over many days and that kind of stake will drive a decent rise if bought on market otherwise will take ages to get that without knocking price higher quickly.
The directors also exist in the world and on that basis have other calls on their money. They may also have there own portfolios of investments and as an decent IFA will suggest should be a multi asset strategy rather than all your personal wealth in one asset. One could argue that directors maybe more free to buy as we likely don't bid for contracts directly so awards out of hands so.more open periods. Those awards we have had historically maybe a mix of tier 1 and direct meaning limits on buying. Buying 200k shares at current price may seem small beans to some but its roughly 10k and for higher earners that's roughly 20k of earnings before tax/ni etc. Directors buying millions at current levels in Nvidia would get investors frothing but ultimately they will be proven to.maybe average poor return on a long term basis if the numbers drift from expectations even may make a loss. Directors in aim companies buying shares can't win with PIs I feel.
Smarteye - nothing new, still saying over a million cars but no definitive figure. 75% revs is research. Awful presentation again. Still heavily trailing software tier 1 status and processor agnostic and working directly with oem engineers rather than tier 1. Make of that what you will- I don't buy it and the valeo, bosch, continental and magna tier 1 would need input and advise thier solution.
Acconeer still interests me. Prob overvalued somewhat but the interior functions their radar facilitates is interesting when linked with optical dms. One to watch.
The q&a discussion hosted by Jesper
Acconeer suggests radar complementary to optical. MK agreed. MK.suggesting sensor data needs fusion and sees imotions as a way of delivering fusion via software on a central computer.
MK talking about reg environment in Japan-likely to follow eu/us regs. Likely universal uptake of ncap like testing.
MK inadvertently making case for easy roll out of dms across global car platforms even if local regs don't require - that really adds weight to easy to bolt on solution, say a mirror....
Smarteye suggesting other applications possible but not looking to create new division like aviation. Focusing on automotive and research - prob realises game over for them in aviation due to cost and market access with Collins sewn up and costs needed to certify for aviation. Smart deal for seeing machines and credit to PMG. Seen off major player that could also have done something different.
Jesper asked about software agnostic vs seeing machine. Completely missed the point that seeing also is just software in the end. Smarteye see them selves as Switzerland of dms. Make of that what you will.
Yep. Royalties I reckon. Could be a chip used for say the valeo solution posted a while back that was a one box solution or for Magna mirror and adas forward facing. Might be overall cheaper solution or more integrated solution than say magna (or someone else) using two chips one for oms/dms and say eyeQ Mobileye forward facing for adas. Could also be if the indie chip took off a way to force Mobileye to license occula npu for future eyeQ chips. All these optimisations and silicon hardware surely must mean something for our overall market share - designing and getting chips manufactured is not cheap endeavour without real live projected sales volumes. These chips may also have some utility in aviation maybe for plane taxiing
safety on the ground alongside pillot monitoring. Who knows? What are we missing here? Car component sourcing is so multilayered.and opaque that although I think seeingmachines will be a portfolio maker for me I probably wouldn't invest in autotech again. The nda, dual sourcing and.multilayered vendor partners wrecks my head!
SEE getting battered down, Smarteye back closer to 40 SEK than over 50 SEK from a few months back in the glow of post fund raise and a couple of design wins. Cipia down lower after some recent spike upwards. Tobii down 50% on year.
Non of the companies are profitable. Smarteye projected like q4 2024. We are projecting similar (end h1 24/25 FY). No idea on Cipia or Tobii. Who will need a cash call first? We do have decent revenue base from Cat, Collins and our Guardian (although our costs are higher but I would argue we have taken a very different route to software only so r and d costs.more and will have significant book value and value accrual further out) Cipia will have Israel investment aspects and headwinds to deal with as well as wider macro. Semiconductor companies partnering to design chips with our dms npu surely is a positive indicator? Not seeing any other.dms provider doing that - they are just adjusting and optimising software for a specific iteration of an arm based chip that also has to run every other software routine stacks. I can't believe you have those 4 companies worth less than half a billion quid total when yearly sales are likely to be 300-400million total in 4 or so years. Massive valuation gap I think. Race to breakeven now and how the award gap of cars in eu/row needing dms by legislation but volume not yet awarded is then attributed. Market realities affecting dms players equally- would want to be raising.money in next 12.months - will be painful.